Nifty
Sensex
:
:
25709.85
83952.19
124.55 (0.49%)
484.53 (0.58%)

Rubber Products

Rating :
67/99

BSE: 530843 | NSE: CUPID

251.93
17-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  253.5
  •  254.64
  •  244.78
  •  253.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1726994
  •  434344680.01
  •  254.64
  •  55.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,750.61
  • 141.55
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,694.67
  • N/A
  • 26.07

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.52%
  • 25.91%
  • 23.35%
  • FII
  • DII
  • Others
  • 0.95%
  • 0.00%
  • 7.27%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.62
  • 4.96
  • 4.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.13
  • 2.98
  • 0.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.90
  • 7.15
  • 9.03

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.02
  • 17.89
  • 43.64

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.42
  • 5.81
  • 8.15

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.16
  • 22.95
  • 32.89

Earnings Forecasts:

(Updated: 18-10-2025)
Description
2024
2025
2026
2027
Adj EPS
15.23
P/E Ratio
16.54
Revenue
180.62
EBITDA
40.76
Net Income
40.89
ROA
11.82
P/B Ratio
19.76
ROE
12.71
FCFF
-17.07
FCFF Yield
-0.3
Net Debt
-136.44
BVPS
12.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
64.75
44.03
47.06%
56.48
62.90
-10.21%
46.35
40.05
15.73%
0.00
0.00
0
Expenses
43.33
32.48
33.41%
43.08
31.99
34.67%
35.01
27.90
25.48%
0.00
0.00
0
EBITDA
21.42
11.55
85.45%
13.40
30.90
-56.63%
11.34
12.15
-6.67%
0.00
0.00
0
EBIDTM
33.08%
26.24%
23.73%
49.13%
24.47%
30.34%
0.00%
0.00%
Other Income
0.00
0.00
0
4.63
2.98
55.37%
4.41
0.73
504.11%
0.00
0.00
0
Interest
0.62
0.23
169.57%
0.78
0.94
-17.02%
0.41
0.39
5.13%
0.00
0.00
0
Depreciation
1.24
0.76
63.16%
1.26
0.74
70.27%
1.29
0.75
72.00%
0.00
0.00
0
PBT
19.55
10.56
85.13%
16.00
32.21
-50.33%
14.05
11.73
19.78%
0.00
0.00
0
Tax
4.54
2.31
96.54%
4.49
8.49
-47.11%
3.01
2.87
4.88%
0.00
0.00
0
PAT
15.01
8.25
81.94%
11.51
23.72
-51.48%
11.04
8.86
24.60%
0.00
0.00
0
PATM
23.18%
18.75%
20.38%
37.71%
23.82%
22.13%
0.00%
0.00%
EPS
0.56
0.31
80.65%
0.43
0.04
975.00%
0.41
0.17
141.18%
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Net Sales
-
183.52
171.71
Net Sales Growth
-
6.88%
 
Cost Of Goods Sold
-
37.79
32.50
Gross Profit
-
145.73
139.21
GP Margin
-
79.41%
81.07%
Total Expenditure
-
141.80
120.99
Power & Fuel Cost
-
7.77
6.79
% Of Sales
-
4.23%
3.95%
Employee Cost
-
27.27
15.66
% Of Sales
-
14.86%
9.12%
Manufacturing Exp.
-
32.10
29.45
% Of Sales
-
17.49%
17.15%
General & Admin Exp.
-
22.93
21.56
% Of Sales
-
12.49%
12.56%
Selling & Distn. Exp.
-
9.69
12.87
% Of Sales
-
5.28%
7.50%
Miscellaneous Exp.
-
4.26
2.15
% Of Sales
-
2.32%
1.25%
EBITDA
-
41.72
50.72
EBITDA Margin
-
22.73%
29.54%
Other Income
-
19.66
6.60
Interest
-
2.05
1.81
Depreciation
-
4.48
2.93
PBT
-
54.86
52.58
Tax
-
13.97
12.73
Tax Rate
-
25.46%
24.21%
PAT
-
40.89
39.85
PAT before Minority Interest
-
40.89
39.85
Minority Interest
-
0.00
0.00
PAT Margin
-
22.28%
23.21%
PAT Growth
-
2.61%
 
EPS
-
1.52
1.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Shareholder's Funds
342.19
301.29
Share Capital
26.85
13.42
Total Reserves
217.01
190.82
Non-Current Liabilities
8.39
1.65
Secured Loans
0.00
0.00
Unsecured Loans
0.00
0.00
Long Term Provisions
2.53
0.32
Current Liabilities
21.20
17.01
Trade Payables
1.25
0.05
Other Current Liabilities
5.14
3.80
Short Term Borrowings
12.63
12.06
Short Term Provisions
2.17
1.10
Total Liabilities
371.78
319.95
Net Block
66.62
58.13
Gross Block
111.34
98.37
Accumulated Depreciation
44.72
40.24
Non Current Assets
89.90
70.25
Capital Work in Progress
6.49
0.00
Non Current Investment
15.66
12.05
Long Term Loans & Adv.
1.12
0.07
Other Non Current Assets
0.00
0.00
Current Assets
281.88
249.69
Current Investments
86.86
135.34
Inventories
41.67
15.65
Sundry Debtors
67.03
47.98
Cash & Bank
68.57
39.45
Other Current Assets
17.74
0.96
Short Term Loans & Adv.
14.79
10.30
Net Current Assets
260.68
232.68
Total Assets
371.78
319.94

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Cash From Operating Activity
-11.37
7.84
PBT
54.86
52.58
Adjustment
-9.51
-1.85
Changes in Working Capital
-43.41
-30.16
Cash after chg. in Working capital
1.93
20.57
Interest Paid
0.00
0.00
Tax Paid
-13.30
-12.73
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
44.91
-79.84
Net Fixed Assets
-19.46
Net Investments
44.64
Others
19.73
Cash from Financing Activity
-1.46
98.77
Net Cash Inflow / Outflow
32.08
26.77
Opening Cash & Equivalents
27.07
0.30
Closing Cash & Equivalent
59.15
27.07

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Book Value (Rs.)
9.08
0.76
ROA
11.82%
12.46%
ROE
18.25%
19.51%
ROCE
17.04%
17.36%
Fixed Asset Turnover
1.75
1.75
Receivable days
114.37
101.99
Inventory Days
57.01
33.27
Payable days
6.27
0.52
Cash Conversion Cycle
165.11
134.74
Total Debt/Equity
0.05
0.06
Interest Cover
27.74
30.05

News Update:


  • Cupid receives CE (EU IVDR) certification for Pregnancy, Syphilis test kits
    20th Oct 2025, 12:30 PM

    The development marks a major step in Cupid’s transition from an Indian healthcare exporter to a globally certified IVD solutions provide

    Read More
  • Cupid enters into term sheet to acquire strategic stake in Mansam
    10th Sep 2025, 11:29 AM

    This strategic investment will enable the company to expand its presence in the lifestyle and consumer space, leveraging opportunities in the high-growth Middle Eastern luxury market

    Read More
  • Cupid - Quarterly Results
    8th Aug 2025, 17:35 PM

    Read More
  • Cupid makes strategic investment in GII Healthcare Investment
    17th Jul 2025, 11:53 AM

    GII Healthcare Investment holds a significant minority equity stake in a prominent healthcare provider based in Saudi Arabia

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.